ArticleBMC veterinary research2026
Serosurveillance and participatory disease surveillance of Peste des Petits Ruminants (PPR) in Georgia and Armenia in 2019-2020.
Article in BMC veterinary research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Peste des petits ruminants (PPR) is a severe viral disease of small ruminants, endemic in Asia, the Middle East, and Africa, and a WOAH and FAO target for eradication. In the last decade, PPR emerged in countries in the Caucasus and Europe. Georgia's first outbreak in 2016 led to multi-year vaccination campaigns in Georgia and neighbouring, PPR-free, Armenia. This was followed by serological surveillance campaigns in 2019-2020 in both countries. In addition, in 2019, participatory diseases surveillance including interviews and focus-group discussions were conducted in four provinces of Georgia. Nearly 6,600 animals were sampled across seven provinces in Georgia and three provinces in Armenia in 2019 and 2020. For each animal, serum and blood samples were collected to test for antibodies and viral RNA, respectively. The participatory disease surveillance identified symptoms compatible with a PPR outbreak in January 2016 near Tbilisi, but not in other locations or time periods. All blood samples were negative for viral RNA, and 23 serum samples were sero-positive but non-clustered in space and time. In the absence of evidence of PPR virus circulation or disease occurrence, we calculated the probability of disease freedom at the time of sampling in both countries, as well as projections for disease freedom under multiple hypothetical sampling scenarios. With a design prevalence and probability of introduction of 5%, we calculated a probability of freedom of 70.8% in Armenia and 73.8% in Georgia for 2021. In the absence of further sampling, these probabilities dropped in subsequent years due to a high risk of re-introduction from PPR-endemic neighbouring countries, exemplified by a novel introduction of PPR in Georgia in 2024. This showcases the need for continued investment in surveillance as well as transboundary collaboration between countries with different disease statuses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.